Abstract: Porphyria cutanea tarda has a complex etiology with genetic factors not completely elucidated. The miscegenation of the Brazilian population has important implications in the predisposition to diseases. There are no studies concerning the genetic ancestry of patients with porphyria cutanea tarda from a mixed population. Thirty patients living in Rio de Janeiro with sporadic porphyria cutanea tarda were studied for the genetic ancestry through informative markers -INDELS. There was a significant predominance of European ancestry across the sample of patients with porphyria cutanea tarda (70.2%), and a small contribution of African and Amerindian ancestry, 20.1% and 10.9%, respectively. Keywords: Porphyria cutanea tarda; Genetics; Genomics; Population characteristics 
Porphyria cutanea tarda (PCT) is the most frequent of all porphyrias and of greatest dermatological interest. It is classified as a chronic hepatic porphyria caused by the reduction in the activity of the enzyme uroporphyrinogen decarboxylase. The etiology is not completely clear, and environmental and genetic factors are needed for the clinical expression of the condition. 1, 2 It is known that the predisposition to different conditions varies considerably in the global population. However, since the Brazilian population went through an intense process of miscegenation, with contributions from Europeans, Africans and Amerindians, this resulted in a highly heterogenous genetic profile little seen in other parts of the world. 3, 4 Because of the Brazilian genetic diversity, despite having a higher frequency of reports of PCT in Caucasian patients, we do not know the potential role of the ancestry as an independent risk factor associated to the condition.
Currently, genetic ancestry has been applied in many populational studies and has a substantial advantage over physical features, since it remains constant throughout life. In mixed populations, they are able to infer the genetic constitution that can result in important implications on the inherited diseases protein profile.
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We did not find in the literature data on the contribution of ancestry using AIMs in patients with PCT. To our knowledge, this is the first study that evaluated genetic ancestry in patients with PCT from a mixed population. Our aim is to investigate the influence of genetic origins to improve the understanding of the mechanisms involved in the predisposition to the disease. This datum supports the fact that most of the studies of PCT groups come from homogenous populations, mainly European, such as Hungary, Sweden, Norway, and so forth 2, 9 , as well as the mutation C282Y in the hereditary hemochromatosis gene, frequent in European descendants, which was also observed in PCT patients, contributing to an iron overload. 9 Manta et al. 10 Therefore, in areas with a higher European ancestry, it would be interesting to organize the health system and incorporate specific diagnostic tests and improving therapeutic guidelines to include PCT.
In sum, in our PCT patient sample from a mixed population, distribution data according to genetic ancestry showed a significant predominance of contribution of European origin. q
